1.
plasma throml oplastin antecedant (PTA)
血浆促凝血酶原激酶前体
2.
tissue thromboplasti
组织促凝血酶原激酶
3.
thromboplastin antecedent
促凝血酶原激酶先质
4.
An enzyme in human urine that catalyzes the conversion of plasminogen to plasmin and is used in medicine to dissolve blood clots.
尿激酶人体尿液中的可促使血将酶原转代成血浆酶的酶，用于溶解血凝块的药物中
5.
Significance of Warfarin and PIVKA-Ⅱ s Plasma Concentration in Anticoagulation Monitoring Following Mechanical Heart Valve Replacment;
华法林和凝血酶原前体蛋白的血浆浓度在心脏机械瓣膜置换术后抗凝监测中的意义
6.
The clinical study of prothrombin precursor protein in monitoring anticoagulation
凝血酶原前体蛋白在抗凝监测中的临床研究
7.
A plasma protein that is converted into thrombin during blood clotting.
凝血原酶一种血浆蛋白质，在血液凝聚时转化成凝血酵素
8.
Influence of Aprotinin to Activated Clotting Time and Whole Blood Prothrombin Time during Cardiopulmonary Bypass;
体外循环下抑肽酶对激活的全血凝固时间和全血凝血酶原时间的影响
9.
The precursor of any of various blood factors necessary for coagulation.
前凝血剂血液凝结所必须的凝血因子的凝血酶原
10.
The inactive precursor to plasmin that is found in body fluids and blood plasma.
血纤维蛋白溶酶原血纤维蛋白溶酶不活跃的前体，常发现于体液和血浆中
11.
A Study on the Effect of Platelet-rich Plasma, Activated by Different Concentrations of Thrombin, on the Repair of Cranial Defects;
不同浓度凝血酶对富血小板血浆促颅骨缺损修复影响的实验研究
12.
Plasma Concentrations Changes and Significance of Plasminogen Activator, Plasminogen Activator Receptor and Plasminogen Activator Inhibitor-1 in Chronic Glomerulonephritis and the Intervenient Research on Them;
慢性肾小球肾炎血浆纤溶酶原激活物及其受体和纤溶酶原激活物抑制剂的变化与干预研究
13.
Relationship between Thrombin Activated Fibrinolysis Inhibitor in Plasma and Vascular Complication in Type 2 Diabetes;
血浆凝血酶激活的纤溶抑制物与2型糖尿病血管并发症的关系
14.
Detection and clinical significance of plasma urokinase-type plasminogen activator and its soluble receptor in multiple myeloma patients;
多发性骨髓瘤患者血浆尿激酶型纤溶酶原激活物及其可溶性受体的检测
15.
DYNAMIC CBSERVATION OF RUMAN P■ASMA KININASE AND■REK A■IIKIEIN IN ACUTE MY■CAI D■A■ NIAIC■ON
急性心肌梗塞患者血浆前激肽释放酶和激肽酶动态变化
16.
congenital aprothrombinemia
先天性凝血酶原缺乏症
17.
Study of the Relativity between Thrombin-activatable Fibrinolysis Inhibtor and Stroke
血浆凝血酶激活的纤溶抑制物与脑卒中的相关性研究
18.
The Relationship between Thrombin-Activatable Fibrinolysis Inhibitor and Risk of Stroke
血浆凝血酶激活的纤溶抑制物与脑卒中的相关性